In 2020, the global medical fluid bag market value was more than $2,531.80 million in 2020. The global medical fluid market is forecast to grow at a compound annual growth rate (CAGR) of more than 4.2% during the forecast period from 2021-2027.

Fluid replacement therapy, blood transfusions, and oral or enteral nutrition all require the use of medical fluid bags to ensure proper body fluid collection, electrolyte imbalances, and patient nutrition. In various biomedical procedures, these bags consist of polymers and include pockets for storing body fluids. 

In addition to an inner pouch, these fluid bags have an outer coating of flexible plastic. The bags and outer layer put inside these bags work together to protect the fluids until the expiration date listed on the bags. These bags are used in healthcare settings with a multipurpose approach to ensure that blood samples are kept in sterilized conditions, preventing the spread of infectious diseases and minimizing the loss of blood samples or medicines. The bags also help administer fluid replacement therapy so that adequate body fluids are collected, blood transfusions occur, electrolyte difference corrections occur, and healthy nutritional intake occurs via oral or enteral means.

Factors Affecting the Market

• Globally, the rise in chronic conditions such as diabetes, cancer, cardiovascular diseases, kidney infections, and liver infections is driving the growth of the medical fluid bags market. 
• Hospitals and healthcare sectors throughout the world have seen a tremendous increase in demand for medical fluid bags. In the coming years, this will create considerable growth opportunities.
• Concerns regarding improper disposal of PVC-based medical fluid bags that may have a detrimental impact on the environment and health problems associated with their use may inhibit the market growth.

Covid-19 Impact

• In its initial phase, the COVID-19 pandemic affected the medical fluid bags market. Coronavirus outbreaks have had a significant economic impact across many countries, causing significant losses and causing an increase in disease burden. There have been severe financial repercussions resulting from the outbreak in several sectors, with the healthcare industry at the forefront. Raw material shipment delays and supply chain disruptions have contributed to the slow growth of the industry.
• WHO released interim guidelines that suggest intravenous fluid treatment for COVID-19 patients who are infected and critically ill. 
• In addition to fluid therapy, the Joint Anesthetic and Intensive Care & International Fluid Academy recommends giving critical patients electrolyte and fluid therapy. Medical fluid bags market revenue will increase with adherence to such guidelines for intravenous bags used in IV therapy. 
• European Society for Clinical Nutrition, Metabolic Disorders (ESPEN) recommends enteral and parenteral nutrition for meeting the daily nutritional needs of COVID-19 patients. 
• The cancellation of elective surgeries and allocation of a significant share of healthcare resources for COVID-19 has resulted in a decline in overall admissions, thereby hampering industry demand.

Regional Overview

• The U.S. dominates the North American market for medical fluid bags due to rising hospital visits and more surgeries across the nation. 
• According to the Healthcare Cost and Utilization Project statistics, to date, more than 17.2 million hospital visits have been recorded in both ambulatory surgical centers and hospitals across the country. 
• The National Center for Health Statistics reports that approximately 48 million inpatient surgeries occur in the United States every year. 
• Since medical fluid bags are essential for surgical operations and are used to drain bodily fluids, supply liquid medication, nutrition, electrolytes, and blood during surgery, they will benefit from the growing number of surgical procedures.

Key Players

The leading prominent companies profiled in the global medical fluid bag market are:

• Thermo Fisher Scientific Inc.
• B. Braun Medical Inc.
• Baxter International Inc.
• Amsino International Inc.
• ConvaTec Group plc
• Hospira Inc.
• Westfield Medical Ltd
• Pall Corporation
• Smiths Medical, Inc.
• Terumo Corporation
• Fresenius Kabi
• Other Prominent Players

Aim of the Report

The global medical fluid bag market segmentation focuses on Product Type, End-User, Material, and Region.

Segmentation based on Product Type

• Blood Bags
• Intravenous Bags
• Drain Bags
• Dialysis Bags
• Others

Segmentation based on End-User

• Hospitals 
• Blood Banks   
• Others 

Segmentation based on Material

• PVC Compounds
• Polyolefins
• Others

Segmentation based on Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • Western Europe
    • The UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Western Europe
  • Eastern Europe
    • Poland
    • Russia
    • Rest of Eastern Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • ASEAN
  • Rest of Asia Pacific
• Middle East & Africa (MEA)
  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of MEA
• South America
  • Brazil
  • Argentina
  • Rest of South America